Search research articles
Contact Us
Filters
Showing results (91-100 of 108) with videos related to
Page
of 11
Sort By:
The Journal of Infectious Diseases
|
June 7, 2024
B-Cell Activation Gene Signature in Blood and Liver of Hepatitis B e Antigen-Positive Patients With Immune Active Chronic Hepatitis B
Zgjim Osmani, Boris J B Beudeker, Zwier M A Groothuismink, et al.
European Journal of Immunology
|
May 30, 2024
Intrahepatic plasma cells, but not atypical memory B cells, associate with clinical phases of chronic hepatitis B
Zgjim Osmani, Martin Arreola Villanueva, Jasmin Joseph-Chazan, et al.
Gut
|
December 24, 2018
Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection
Ruben C Hoogeveen, Maxwell P Robidoux, Tatjana Schwarz, et al.
Plos One
|
October 7, 2015
ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection
Raoel Maan, Adriaan J van der Meer, Willem Pieter Brouwer, et al.
Hepatology Communications
|
September 14, 2023
Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe
Boris J B Beudeker, Siyu Fu, Domingo Balderramo, et al.
Lancet Regional Health. Americas
|
December 10, 2024
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes
Leonardo G da Fonseca, Laura Izquierdo-Sanchez, Pedro H Hashizume, et al.
Antiviral Therapy
|
February 4, 2012
Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7
Andre Boonstra, Bi-Sheng Liu, Zwier M A Groothuismink, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 14, 2020
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)
Milan J Sonneveld, Jun Yong Park, Apichat Kaewdech, et al.
JHEP Reports : Innovation in Hepatology
|
April 8, 2026
A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells
Nicolaas Van Renne, Fleur Ballet, Stijn Van Hees, et al.
The Journal of Infectious Diseases
|
January 28, 2026
Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study
Anabella Clara Fantilli, María Belén Pisano, Maribel Martínez Wassaf, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 108) with videos related to
Sort By:
Page
of 11
The Journal of Infectious Diseases
|
June 7, 2024
B-Cell Activation Gene Signature in Blood and Liver of Hepatitis B e Antigen-Positive Patients With Immune Active Chronic Hepatitis B
Zgjim Osmani, Boris J B Beudeker, Zwier M A Groothuismink, et al.
European Journal of Immunology
|
May 30, 2024
Intrahepatic plasma cells, but not atypical memory B cells, associate with clinical phases of chronic hepatitis B
Zgjim Osmani, Martin Arreola Villanueva, Jasmin Joseph-Chazan, et al.
Gut
|
December 24, 2018
Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection
Ruben C Hoogeveen, Maxwell P Robidoux, Tatjana Schwarz, et al.
Plos One
|
October 7, 2015
ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection
Raoel Maan, Adriaan J van der Meer, Willem Pieter Brouwer, et al.
Hepatology Communications
|
September 14, 2023
Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe
Boris J B Beudeker, Siyu Fu, Domingo Balderramo, et al.
Lancet Regional Health. Americas
|
December 10, 2024
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes
Leonardo G da Fonseca, Laura Izquierdo-Sanchez, Pedro H Hashizume, et al.
Antiviral Therapy
|
February 4, 2012
Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7
Andre Boonstra, Bi-Sheng Liu, Zwier M A Groothuismink, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 14, 2020
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)
Milan J Sonneveld, Jun Yong Park, Apichat Kaewdech, et al.
JHEP Reports : Innovation in Hepatology
|
April 8, 2026
A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells
Nicolaas Van Renne, Fleur Ballet, Stijn Van Hees, et al.
The Journal of Infectious Diseases
|
January 28, 2026
Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study
Anabella Clara Fantilli, María Belén Pisano, Maribel Martínez Wassaf, et al.
Page
of 11